Search Results 1301-1310 of 21991 for Inhibition
... studies inflammatory bowel disease such as ulcerative colitis and Crohn's disease, as well as immune checkpoint inhibitor-induced colitis and CAR-T enteritis.
progression on prior c-Met inhibitor), Cohort C: basket of tumor types with c-Met high level amplification (except Primary CNS tumors), Cohort C-1: NSCLC ...
... inhibitor therapy, or failed to achieve a PR following 12 weeks of BTK inhibitor therapy. -Presence of evaluable disease -Adequate bone marrow and organ ...
Subject with prior exposure to p40 inhibitors (e.g., ustekinumab [Stelara]) or p19 inhibitors (e.g., risankizumab). Subject has been taking combination of ...
Examples may include but are not limited to corticosteroid agents given orally or intravenously, cyclosporine, tacrolimus, or tumor necrosis factor inhibitors.
Use of a strong inhibitors or inducers of cytochrome P450 (CYP) 3A or p-glycoprotein. Current smoker. History of alcohol abuse within 6 months of the study ...
Prolonged inhibition of presynaptic catecholamine synthesis with alpha-methyl-para-tyrosine attenuates the circadian rhythm of human TSH secretion. J Soc ...
... Inhibition in Advanced Malignancies Scottsdale/Phoenix, AZ; Jacksonville, FL; Rochester, MN. The purpose of this study is to evaluate ALPN-202 with PD-1 ...
Antidepressants. Selective serotonin reuptake inhibitors (SSRIs) — which include fluoxetine (Prozac), paroxetine (Paxil, Pexeva), sertraline (Zoloft) and others ...
McKinley BJ, Santiago M, Pak C, Nguyen N, Zhong Q. Pneumatosis Intestinalis Induced by Alpha-Glucosidase Inhibitors in Patients with Diabetes Mellitus. J ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!